Bio Farma

Bio Farma The Leading Vaccine Manufacturer in Indonesia & The Largest in South East Asia | This Official Account Manage by Bio Farma's Corp. Communication Team

About BioFarma

Supported by competence and experience for more than 125 years of learning, Bio Farma, a state-owned enterprise in Indonesia, manufacturing and distributing vaccines and one of a few WHO pre-qualified vaccine manufacturers, is here as part of the struggle to protect and increase the quality of human life. Playing an important role to establish a healthy nation in which its existence would be maintained for generations to come. With our philosophy of being “Dedicated to improve Quality of Life,” we are ready to devote our efforts to Global Health Security, so through Biotech for a better future provides solutions for global prosperity. Bio Farma focuses on research, development, production, marketing and distribution of biological and pharmaceutical products both nationally and globally. Bio Farma plays an active role in advancing the vaccine research and technology, conducting research on new vaccines in the effort of maintaining a sustainable vaccine supply in the country and also the availability of vaccines to meet the global needs of high quality and affordable vaccines. For more information on Bio Farma please contact us or visit us at www.biofarma.co.id.

• The official Instagram account name is https://www.instagram.com/biofarmaID/
• The official Youtube account name is https://www.youtube.com/biofarmaID/
• The official Twitter account name is https://twitter.com/biofarmaID

Side meeting di hari kedua berjalan begitu cepat dan setiap pembahasan membawa arah baru dalam dunia kesehatan.Dari pemb...
06/11/2025

Side meeting di hari kedua berjalan begitu cepat dan setiap pembahasan membawa arah baru dalam dunia kesehatan.
Dari pembaruan teknologi hingga peluang riset bersama, Bio Farma dan Partner Global terus menyatukan langkah untuk memperkuat inovasi dan kerja sama jangka panjang.

Di balik agenda besar 26th DCVMN AGM (Developing Countries Vaccine Manufacturers Network Annual General Meeting), sesi seperti ini juga akan mendorong banyak keputusan penting terjadi, keputusan yang pada akhirnya akan menghadirkan vaksin yang lebih aman, riset yang lebih cepat, dan akses layanan kesehatan yang lebih merata bagi masyarakat.

Day 2 of the 26th DCVMN AGM (Developing Countries Vaccine Manufacturers Network Annual General Meeting) brought a series...
05/11/2025

Day 2 of the 26th DCVMN AGM (Developing Countries Vaccine Manufacturers Network Annual General Meeting) brought a series of meaningful conversations from improving systems and strengthening collaboration to exploring what the future of immunisation could look like. Each session added a piece to the same mission: building a vaccine ecosystem that’s stronger, more reliable, and ready for the challenges ahead.

Pengangkatan Iin Susanti sebagai Board Chair DCVMN 2026–2029 menandai langkah besar bagi Indonesia dalam memperkuat posi...
05/11/2025

Pengangkatan Iin Susanti sebagai Board Chair DCVMN 2026–2029 menandai langkah besar bagi Indonesia dalam memperkuat posisi dan kontribusinya di panggung kesehatan global.

Indonesia melalui Bio Farma diharapkan dapat semakin memperluas kolaborasi. solidaritas dan pertukaran informasi dengan negara-negara lain, terutama dalam rmembuka peluang kerja sama teknologi baru untuk pengembangan vaksin yang lebih cepat, terjangkau, dan berkeadilan.

Di setiap sesi, Bio Farma berdiskusi dengan berbagai partner internasional untuk menyelaraskan langkah, bertukar pemikir...
04/11/2025

Di setiap sesi, Bio Farma berdiskusi dengan berbagai partner internasional untuk menyelaraskan langkah, bertukar pemikiran, dan melihat peluang kolaborasi yang bisa dikembangkan bersama.

Walaupun durasinya singkat, tiap pertemuan membawa sudut pandang baru, mulai dari teknologi, strategi bisnis, hingga rencana pengembangan produk yang bisa memperkuat kesiapsiagaan kesehatan di masa depan. Karena kemajuan di bidang kesehatan bukan terdiri dari satu institusi, tapi dari banyak pihak yang memilih bergerak bersama demi kesehatan dunia yang lebih baik.

Day 1 of the 26th DCVMN AGM wrapped with big conversations on funding gaps, new technologies, and the future of vaccine ...
03/11/2025

Day 1 of the 26th DCVMN AGM wrapped with big conversations on funding gaps, new technologies, and the future of vaccine manufacturing. From navigating a shifting global economy to exploring smarter, more inclusive financing, leaders and manufacturers from Asia, Africa, and Latin America shared one commitment: keeping vaccine access fair and sustainable for everyone.

The 26th DCVMN AGM opened with a clear message from global health leaders: deeper collaboration, stronger regional manuf...
03/11/2025

The 26th DCVMN AGM opened with a clear message from global health leaders: deeper collaboration, stronger regional manufacturing, and fair access to vaccines for all. From WHO, Gavi, CEPI, PAHO, Africa CDC to Indonesia’s Ministry of Health, the call was the same, health resilience is possible when we move forward together.

Indonesia Best CMO Awards 2025 mengusung tema “Redefining the CMO Role in Indonesia’s Dynamic Market Landscape to Shape ...
01/11/2025

Indonesia Best CMO Awards 2025 mengusung tema “Redefining the CMO Role in Indonesia’s Dynamic Market Landscape to Shape the Future of Brand and Business Growth”. Tema ini menegaskan bahwa peran CMO kini bukan hanya soal kampanye, tapi bagaimana memimpin strategi yang mampu menjawab dinamika pasar dan mendorong pertumbuhan brand serta bisnis jangka panjang.

Penilaiannya mencakup empat aspek: kreativitas strategi pemasaran, pengelolaan brand equity & influence, transformasi digital yang berfokus pada pelanggan, serta visibilitas brand dan eksposur media. CMO dianggap unggul bila mampu membangun citra positif perusahaan sekaligus tampil lebih kuat dari kompetitor.

31/10/2025

Menutup agenda DCVMN AGM 2025 pada hari ketiga dengan rangkaian yang penuh wawasan!

Dari penguatan kapasitas produksi negara berkembang, kolaborasi kawasan ASEAN, pemanfaatan AI, hingga transformasi digital dalam sistem kesehatan.

Diskusi hari ini menunjukkan bahwa inovasi bukan hanya teknologi, tapi juga bagaimana cara dunia berinovasi bersama untuk memperkuat kemandirian vaksin dan mempercepat akses bagi semua kalangan.

DCVMN AGM 2025 telah berakhir, namun komitmen untuk menghadirkan dunia yang lebih aman terus berlanjut tanpa henti!

Berawal sebagai dokter di Republik Demokratik Kongo, Dr. Jean Kaseya kini memimpin Africa Centres for Disease Control an...
28/10/2025

Berawal sebagai dokter di Republik Demokratik Kongo, Dr. Jean Kaseya kini memimpin Africa Centres for Disease Control and Prevention (Africa CDC), memperjuangkan sistem kesehatan yang mandiri dan tangguh di seluruh Afrika.

Kehadirannya di DCVMN Annual General Meeting ke-26 di Bali menjadi simbol kolaborasi lintas benua untuk masa depan kesehatan yang lebih kuat dan setara.

Address

Jalan Pasteur No . 28 Bandung
Bandung
40161

Opening Hours

Monday 07:10 - 16:10
Tuesday 07:10 - 16:00
Wednesday 07:10 - 16:10
Thursday 07:10 - 16:00
Friday 07:10 - 16:00

Telephone

+621500810

Website

Alerts

Be the first to know and let us send you an email when Bio Farma posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Bio Farma:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

BIO FARMA

About BioFarma Supported by competence and experience for more than 125 years of learning, Bio Farma, a state-owned enterprise in Indonesia, manufacturing and distributing vaccines and one of a few WHO pre-qualified vaccine manufacturers, is here as part of the struggle to protect and increase the quality of human life. Playing an important role to establish a healthy nation in which its existence would be maintained for generations to come. With our philosophy of being “Dedicated to improve Quality of Life,” we are ready to devote our efforts to Global Health Security, so through Biotech for a better future provides solutions for global prosperity. Bio Farma focuses on research, development, production, marketing and distribution of biological and pharmaceutical products both nationally and globally. Bio Farma plays an active role in advancing the vaccine research and technology, conducting research on new vaccines in the effort of maintaining a sustainable vaccine supply in the country and also the availability of vaccines to meet the global needs of high quality and affordable vaccines. For more information on Bio Farma please contact us or visit us at www.biofarma.co.id. • The official Instagram account name is @biofarmaID https://www.instagram.com/biofarmaID/ • The official Youtube account name is @biofarmaID https://www.youtube.com/biofarmaID/ • The official Twitter account name is @biofarmaID https://twitter.com/biofarmaID